These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 19189321)

  • 61. Neurofibromatosis type 1 gene haploinsufficiency reduces AP-1 gene expression without abrogating the anabolic effect of parathyroid hormone.
    Yu X; Milas J; Watanabe N; Rao N; Murthy S; Potter OL; Wenning MJ; Clapp WD; Hock JM
    Calcif Tissue Int; 2006 Mar; 78(3):162-70. PubMed ID: 16525748
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Adult-Onset Deletion of β-Catenin in (10kb)Dmp1-Expressing Cells Prevents Intermittent PTH-Induced Bone Gain.
    Kedlaya R; Kang KS; Hong JM; Bettagere V; Lim KE; Horan D; Divieti-Pajevic P; Robling AG
    Endocrinology; 2016 Aug; 157(8):3047-57. PubMed ID: 27253995
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Skeletal unloading alleviates the anabolic action of intermittent PTH(1-34) in mouse tibia in association with inhibition of PTH-induced increase in c-fos mRNA in bone marrow cells.
    Tanaka S; Sakai A; Tanaka M; Otomo H; Okimoto N; Sakata T; Nakamura T
    J Bone Miner Res; 2004 Nov; 19(11):1813-20. PubMed ID: 15476581
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The Optimal Duration of PTH(1-34) Infusion Is One Hour per Day to Increase Bone Mass in Rats.
    Shimizu M; Noda H; Joyashiki E; Nakagawa C; Asanuma K; Hayasaka A; Kato M; Nanami M; Inada M; Miyaura C; Tamura T
    Biol Pharm Bull; 2016; 39(4):625-30. PubMed ID: 26822531
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Short-term intermittent PTH 1-34 administration enhances bone formation in SCID/Beige mice.
    Sheehan S; Muthusamy A; Paul E; Sikes RA; Gomes RR
    Endocr J; 2010; 57(5):373-82. PubMed ID: 20139633
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Anabolic action of parathyroid hormone (PTH) does not compromise bone matrix mineral composition or maturation.
    Vrahnas C; Pearson TA; Brunt AR; Forwood MR; Bambery KR; Tobin MJ; Martin TJ; Sims NA
    Bone; 2016 Dec; 93():146-154. PubMed ID: 27686599
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Accretion of bone mass and strength with parathyroid hormone prior to the onset of estrogen deficiency can provide temporary beneficial effects in skeletally mature rats.
    Shen V; Birchman R; Liang XG; Wu DD; Dempster DW; Lindsay R
    J Bone Miner Res; 1998 May; 13(5):883-90. PubMed ID: 9610753
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Upregulation of calcitriol during pregnancy and skeletal recovery after lactation do not require parathyroid hormone.
    Kirby BJ; Ma Y; Martin HM; Buckle Favaro KL; Karaplis AC; Kovacs CS
    J Bone Miner Res; 2013 Sep; 28(9):1987-2000. PubMed ID: 23505097
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment.
    Sawakami K; Robling AG; Ai M; Pitner ND; Liu D; Warden SJ; Li J; Maye P; Rowe DW; Duncan RL; Warman ML; Turner CH
    J Biol Chem; 2006 Aug; 281(33):23698-711. PubMed ID: 16790443
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats.
    Meng XW; Liang XG; Birchman R; Wu DD; Dempster DW; Lindsay R; Shen V
    J Bone Miner Res; 1996 Apr; 11(4):421-9. PubMed ID: 8992872
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Early effects of short-term parathyroid hormone administration on bone mass, mineral content, and strength in female rats.
    Toromanoff A; Ammann P; Riond JL
    Bone; 1998 Mar; 22(3):217-23. PubMed ID: 9514214
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Bone Matrix Composition Following PTH Treatment is Not Dependent on Sclerostin Status.
    Ross RD; Mashiatulla M; Robling AG; Miller LM; Sumner DR
    Calcif Tissue Int; 2016 Feb; 98(2):149-57. PubMed ID: 26514840
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Anabolic effects of human biosynthetic parathyroid hormone fragment (1-34), LY333334, on remodeling and mechanical properties of cortical bone in rabbits.
    Hirano T; Burr DB; Turner CH; Sato M; Cain RL; Hock JM
    J Bone Miner Res; 1999 Apr; 14(4):536-45. PubMed ID: 10234574
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Intermittent Ibandronate Maintains Bone Mass, Bone Structure, and Biomechanical Strength of Trabecular and Cortical Bone After Discontinuation of Parathyroid Hormone Treatment in Ovariectomized Rats.
    Takeda S; Sakai S; Tanaka K; Tomizawa H; Serizawa K; Yogo K; Urayama K; Hashimoto J; Endo K; Matsumoto Y
    Calcif Tissue Int; 2017 Jul; 101(1):65-74. PubMed ID: 28246925
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Randomized trial of once-weekly parathyroid hormone (1-84) on bone mineral density and remodeling.
    Black DM; Bouxsein ML; Palermo L; McGowan JA; Newitt DC; Rosen E; Majumdar S; Rosen CJ;
    J Clin Endocrinol Metab; 2008 Jun; 93(6):2166-72. PubMed ID: 18349061
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Lipoprotein receptor-related protein 6 is required for parathyroid hormone-induced Sost suppression.
    Li C; Wang W; Xie L; Luo X; Cao X; Wan M
    Ann N Y Acad Sci; 2016 Jan; 1364(1):62-73. PubMed ID: 25847683
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Parathyroid hormone (PTH)-induced bone gain is blunted in SOST overexpressing and deficient mice.
    Kramer I; Loots GG; Studer A; Keller H; Kneissel M
    J Bone Miner Res; 2010 Feb; 25(2):178-89. PubMed ID: 19594304
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Nuclear Matrix Protein 4 Is a Novel Regulator of Ribosome Biogenesis and Controls the Unfolded Protein Response via Repression of Gadd34 Expression.
    Young SK; Shao Y; Bidwell JP; Wek RC
    J Biol Chem; 2016 Jun; 291(26):13780-8. PubMed ID: 27129771
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of cerivastatin and parathyroid hormone on the lumbar vertebra of aging male Sprague-Dawley rats.
    Banu J; Kalu DN
    Bone; 2002 Jul; 31(1):173-9. PubMed ID: 12110431
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Control of Bone Anabolism in Response to Mechanical Loading and PTH by Distinct Mechanisms Downstream of the PTH Receptor.
    Delgado-Calle J; Tu X; Pacheco-Costa R; McAndrews K; Edwards R; Pellegrini GG; Kuhlenschmidt K; Olivos N; Robling A; Peacock M; Plotkin LI; Bellido T
    J Bone Miner Res; 2017 Mar; 32(3):522-535. PubMed ID: 27704638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.